Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism

• Published in: Hormone research Vol. 36; no. 5-6; p. 192
• Main Authors: Giustina, A, Buffoli, M G, Bussi, A R, Wehrenberg, W B
• Format: Journal Article
• Language: English
• Published: Switzerland 01.01.1991
• Subjects: Adult; Clonidine - administration & dosage; Clonidine - pharmacology; Female; Graves Disease - blood; Graves Disease - physiopathology; Growth Hormone - blood; Growth Hormone - secretion; Growth Hormone-Releasing Hormone - administration & dosage; Growth Hormone-Releasing Hormone - pharmacology; Humans; Hyperthyroidism - blood; Hyperthyroidism - physiopathology; Infusions, Intravenous; Injections, Intravenous; Middle Aged
• ISSN: 0301-0163
• DOI: 10.1159/000182159

Patients with hyperthyroidism have reduced growth hormone (GH) responses to pharmacological stimuli and reduced spontaneous nocturnal GH secretion. The stimulatory effect of clonidine on GH secretion has been suggested to depend on an enhancement of hypothalamic GH-releasing hormone (GHRH) release. The aim of our study was to evaluate the effects of clonidine and GHRH on GH secretion in patients with hyperthyroidism. Eight hyperthyroid females with recent diagnosis of Graves' disease (age range 20-55 years, body mass index range 19.2-26.2 kg/m2) and 6 healthy female volunteers (age range 22-35 years, body mass index range 19-25 kg/m2) underwent two experimental trials at no less than 7-day intervals: (a) an intravenous infusion of clonidine 150 micrograms in 10 ml of saline, or (b) a bolus intravenous injection of human GHRH (1-29)NH2, 100 micrograms in 1 ml of saline. Hyperthyroid patients showed blunted GH peaks after clonidine (7.1 +/- 1.7 micrograms/l) as compared to normal subjects receiving clonidine (28.5 +/- 4.9 micrograms/l, p less than 0.05). GH peaks after GHRH were also significantly lower in hyperthyroid subjects (8.0 +/- 1.7 micrograms/l) as compared to normal subjects receiving GHRH (27.5 +/- 4.4 micrograms/l, p less than 0.05). No significant differences in the GH values either after clonidine or GHRH were observed in the two groups of subjects examined. Our data demonstrate that the GH responses to clonidine as well as to GHRH in patients with hyperthyroidism are inhibited in a similar fashion with respect to normal subjects.